RSNA 2014 

Abstract Archives of the RSNA, 2014


NRE019-b

MRI of Myelin Water: Principles and Applications of an Emerging Technique

Education Exhibits

Presented in 2014

Participants

Cornelia Laule PhD, Presenter: Nothing to Disclose
Irene M. Vavasour PhD, Abstract Co-Author: Nothing to Disclose
Shannon H. Kolind PhD, Abstract Co-Author: Nothing to Disclose
Thorarin Albert Bjarnason PhD, Abstract Co-Author: Nothing to Disclose
Jing Zhang PhD, Abstract Co-Author: Nothing to Disclose
Donna J. Lang DPhil, DSc, Abstract Co-Author: Nothing to Disclose
Piotr Kozlowski PhD, Abstract Co-Author: Nothing to Disclose
Alexander Rauscher PhD, MSc, Abstract Co-Author: Advisory Board, F. Hoffmann-La Roche Ltd
Lara Boyd PhD, Abstract Co-Author: Nothing to Disclose
Anthony Traboulsee MD, Abstract Co-Author: Researcher, Angiotech Pharmaceuticals, Inc Researcher, Bayer AG Researcher, BioMS Medical Researcher, Johnson & Johnson Researcher, DAIICHI SANKYO Group Researcher, F. Hoffmann-La Roche Ltd Researcher, Merck KGaA Researcher, Schering-Plough Corporation Researcher, Teva Pharmaceutical Industries Ltd Researcher, sanofi-aventis Group Researcher, Transition Therapeutics Inc Consultant, sanofi-aventis Group Research Grant, F. Hoffmann-La Roche Ltd Research Grant, sanofi-aventis Group
G.R.Wayne Moore MD, Abstract Co-Author: Nothing to Disclose
David Kwok Boon Li MD, Abstract Co-Author: Researcher, sanofi-aventis Group Researcher, F. Hoffmann-La Roche Ltd Researcher, Merck KGaA Researcher, Novartis AG Researcher, Nuron Biotech, Inc Researcher, PAREXEL International Corporation Consultant, sanofi-aventis Group Consultant, F. Hoffmann-La Roche Ltd Scientific Advisory Board, Novartis AG Scientific Advisory Board, Nuron Biotech, Inc Scientific Advisory Board, Opexa Therapeutics, Inc
Alex L. MacKay PhD, Abstract Co-Author: Nothing to Disclose

TEACHING POINTS

The purpose of this exhibit is: 1. To explain the anatomical basis of myelin water 2. To describe the MRI acquisition and analysis of multi-echo T2-relaxation based myelin water imaging 3. To summarize key myelin water imaging findings in healthy brain and spinal cord tissue 4. To review myelin water imaging abnormalities in different central nervous system pathological conditions including multiple sclerosis, stroke, schizophrenia, concussion and phenylketonuria 5. To learn how myelin water findings compare to other advanced neuroimaging MR techniques such as diffusion tensor and magnetization transfer imaging  

TABLE OF CONTENTS/OUTLINE

1. What is the value of measuring myelin? 2. Background on myelin water imaging technique     a. Anatomical basis of myelin water     b. Data acquisition     c. Data analysis 3. Is myelin water actually related to myelin? Histological validation in preclinical models and post-mortem human tissue 4. Myelin water in healthy tissue     a. Brain     b. Spinal cord 5. Myelin water in pathological tissue     a. Multiple sclerosis     b. Stroke     c. Schizophrenia     d. Concussion     e. Phenylketonuria 6. Comparison of myelin water to other advanced neuroimaging methods 7. What is the significance and future of myelin water imaging?      

PDF UPLOAD

http://abstract.rsna.org/uploads/2014/14008255/14008255_hzdr.pdf

Cite This Abstract

Laule, C, Vavasour, I, Kolind, S, Bjarnason, T, Zhang, J, Lang, D, Kozlowski, P, Rauscher, A, Boyd, L, Traboulsee, A, Moore, G, Li, D, MacKay, A, MRI of Myelin Water: Principles and Applications of an Emerging Technique.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14008255.html